Internal Medicine, Hematology & Oncology · New Orleans, LA
NPI
1407146418
Since 2011
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1514 Jefferson Hwy
New Orleans, LA, 70121
Phone (504) 842-3910
Groups this clinician bills Medicare through
Medicare paid, 2024
$75K
958 services
Medicare patients, 2024
260
Average age 71
Drug cost, 2024
$6.3M
2,616 prescriptions
Company payments, 2025
$16K
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Carter T Davis was code 99215 (office e&m - established), 290 times for 106 patients. In total Carter T Davis billed 958 services in 14 codes, and Medicare paid $75K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 290 | 106 | $104.51 | $30K |
| 99233 Hospital E&M - Subsequent | Facility | 163 | 50 | $89.56 | $15K |
| 99214 Office E&M - Established | Facility | 144 | 94 | $63.41 | $9,131 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 125 | 55 | $12.63 | $1,579 |
| 99215 Office E&M - Established | Office | 78 | 30 | $134.27 | $10K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 34 | 14 | $12.63 | $429 |
| 99213 Office E&M - Established | Facility | 27 | 20 | $44.96 | $1,214 |
| 99232 Hospital E&M - Subsequent | Facility | 22 | 13 | $49.49 | $1,089 |
| 99238 Hospital Discharge Management | Facility | 20 | 17 | $55.79 | $1,116 |
| 99205 Office E&M - New | Facility | 16 | 16 | $136.38 | $2,182 |
By year: 2022 $67K for 735 services; 2023 $62K for 689 services; 2024 $75K for 958 services.
Medicare prescription drug claims, 2024
In 2024, the drug Carter T Davis prescribed most often to Medicare patients was Acyclovir, with 371 prescriptions and refills. In total Carter T Davis wrote 2,616 Medicare prescriptions that cost $6.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 371 | 509 | 81 | $4,883 |
| Venclexta Venetoclax | 181 | 183 | 33 | $1.1M |
| Eliquis Apixaban | 123 | 148 | 23 | $86K |
| Allopurinol Generic | 92 | 177 | 38 | $687 |
| Prednisone Generic | 90 | 100 | 30 | $301 |
| Hydroxyurea Generic | 69 | 174 | 21 | $2,202 |
| Gabapentin Generic | 66 | 86 | 15 | $873 |
| Levofloxacin Generic | 61 | 73 | 30 | $823 |
| Olanzapine Generic | 60 | 60 | 13 | $239 |
| Jakafi Ruxolitinib Phosphate | 57 | 57 | Under 11 | $876K |
| Ondansetron Odt Ondansetron | 50 | 53 | 26 | $956 |
| Potassium Chloride Generic | 48 | 76 | 15 | $883 |
| Prochlorperazine Maleate Generic | 47 | 47 | 24 | $441 |
| Ondansetron Hcl Generic | 47 | 47 | 12 | $385 |
| Revlimid Lenalidomide | 46 | 46 | 11 | $783K |
Brand drugs: - claims; generic drugs: 1,922 claims; opioid claims: 122.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Carter T Davis $16K ($16K in general payments such as food, travel and fees) from 14 companies. The largest payer was Adc Therapeutics America, Inc. with $12K.
| Company | Payments | Amount |
|---|---|---|
| Adc Therapeutics America, Inc. | 10 | $12K |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $2,875 |
| Abbvie Inc. ABBV | 3 | $290 |
| Celgene Corporation BMY | 9 | $282 |
| BeOne Medicines USA, Inc. ONC | 6 | $227 |
| Regeneron Pharmaceuticals, Inc. REGN | 2 | $150 |
| Pierre Fabre Pharmaceuticals, Inc. | 1 | $52.83 |
| Incyte Corporation INCY | 1 | $40.82 |
| Kite Pharma, Inc. GILD | 2 | $34.34 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $32.1 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.